Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

20S Proteasome β7 Inhibitors

The chemical class of 20S Proteasome β7 inhibitors encompasses a range of compounds primarily designed to target proteolytic activities within the proteasome complex. The proteasome is responsible for degrading ubiquitinated proteins and regulating protein turnover. Inhibition of the proteasome's function can affect various cellular processes, including the cell cycle, apoptosis, and the stress response. The β7 subunit is part of the 20S core particle, which has three peptidase activities: caspase-like (β1), trypsin-like (β2), and chymotrypsin-like (β5). While many inhibitors specifically target the chymotrypsin-like activity, there is cross-reactivity, and β7 activity can also be inhibited, either directly or indirectly.

The chemical class of 20S Proteasome β7 inhibitors includes a diverse group of compounds that interact with the proteasome complex, a pivotal player in cellular homeostasis through the degradation of ubiquitinated proteins. This degradation is critical for several cellular processes such as cell cycle regulation, signal transduction, and stress responses. Compounds in this class are characterized by their ability to impair the proteasome's function, thus influencing protein turnover and the fate of proteins destined for degradation. The β7 subunit is part of the 20S core of the proteasome, a multi-catalytic proteinase complex, and is involved in the peptidase activities of the proteasome.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Reversibly inhibits the 20S proteasome's chymotrypsin-like activity, affecting β5 but also impacts β1 and β7.

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

Irreversibly binds to and inhibits the chymotrypsin-like site of the 20S proteasome, including β7 subunit.

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

A boronate peptide that selectively and reversibly inhibits the β5 subunit of the 20S proteasome and may impact β7.

Oprozomib

935888-69-0sc-477447
2.5 mg
$280.00
(0)

An epoxyketone-based proteasome inhibitor, targeting the β5 subunit with potential impact on β7.

Caspofungin acetate

179463-17-3sc-362016
sc-362016A
1 mg
25 mg
$286.00
$5100.00
(1)

A beta-lactone peptide that irreversibly binds to and inhibits all three proteolytic activities of the proteasome, including β7.

UCH-L1 Inhibitor Inhibitor

668467-91-2sc-356182
10 mg
$204.00
1
(1)

A boronic acid derivative that inhibits the chymotrypsin-like activity of the proteasome, including β7.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A peptide aldehyde that reversibly inhibits the chymotrypsin-like and peptidylglutamyl-peptide hydrolyzing activity of the proteasome, affecting β7.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Specifically inhibits the proteasome by covalently modifying its catalytic threonine residues, including those in β7.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

A naturally occurring epoxyketone that irreversibly inhibits the proteasome, including the β7 subunit.

ONX 0914

960374-59-8sc-477437
5 mg
$245.00
(0)

Selectively inhibits the immunoproteasome subunit LMP7, which is analogous to the constitutive β7, potentially affecting similar pathways.